Robert Goeltz II - Chief Financial Officer at Arcus Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
RCUS on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Robert Goeltz II - trading volume in the past year for Arcus Biosciences, Inc.

Holdings reported by Robert Goeltz II for Arcus Biosciences, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 73.8 K $1.55 M $21.00 Jan 23, 2024 Direct
Stock Option (right to buy) 86.6 K Jan 23, 2024 Direct Common Stock

Transactions reported by Robert Goeltz II for Arcus Biosciences, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership